SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

43.53

39519.89

EPS(TTM)

Face Value()

Div & Yield %

53.59

2.44

Back

sunteck realty ltd

Andhra Cements reports standalone net loss of Rs 44.14 crore in the December 2025 quarter

Jan 21,2026

Net Loss of Andhra Cements reported to Rs 44.14 crore in the quarter ended December 2025 as against net loss of Rs 43.73 crore during the previous quarter ended December 2024. Sales rose 66.23% to Rs 110.26 crore in the quarter ended December 2025 as against Rs 66.33 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	110.26	66.33	66
OPM %	4.60	-12.53	-
PBDT	-20.69	-25.37	18
PBT	-44.14	-43.73	-1
NP	-44.14	-43.73	-1

76,802.90 -607.08 ( -0.78%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)